Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Stachler

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Gastrointestinal Endoscopy Clinics of North America|November 19, 2025
Current Concepts for Diagnosing Non-Dysplastic and Dysplastic Barrett's EsophagusMatthew Stachler, Yekta Metanat, Joseph Willis
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 16, 2014
Filter Paper-based Nucleic Acid Storage in High-throughput Solid Tumor GenotypingMatthew Stachler, Yonghui Jia, Nematullah Sharaf, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 10, 2018
Mutational landscape of goblet cell carcinoids and adenocarcinoma ex goblet cell carcinoids of the appendix is distinct from typical carcinoids and colorectal adenocarcinomasMelanie Johncilla, Matthew Stachler, Joseph Misdraji, et al.
Genes|July 27, 2022
Pilot Study Showing Feasibility of Phosphoproteomic Profiling of Pathway-Level Molecular Alterations in Barrett's EsophagusJarrod Moore, Ryan Hekman, Benjamin C Blum, et al.
The American Journal of Gastroenterology|February 25, 2026
Adjunctive Use of p53 Immunohistochemistry for Risk Stratification in Barrett's Esophagus: A Systematic Review and Meta-AnalysisTarek Sawas, Perica Davitkov, Margaret Zhou, et al.
Cold Spring Harbor Molecular Case Studies|June 2, 2021
Twists and turns from "tumor in tumor" profiling: surveillance of chronic lymphocytic leukemia (CLL) leads to detection of a lung adenocarcinoma, whose genomic characterization alters the original hematologic diagnosisPanieh Terraf, Lynette M Sholl, Matthew S Davids, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
Critical role for IL-1β in DNA damage-induced mucositisNaama Kanarek, Sergei I Grivennikov, Michael Leshets, et al.
Nature Communications|January 7, 2017
CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinomaJin Zhou, Zhong Wu, Gabrielle Wong, et al.
Gut|June 10, 2018
Subtypes of Barrett's oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysisMing Yu, Sean K Maden, Matthew Stachler, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Concerted epithelial and stromal changes during progression of Barrett's Esophagus to invasive adenocarcinoma exposed by multi-scale, multi-omics analysisMichael K Strasser, David L Gibbs, Philippe Gascard, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Gastrointestinal Endoscopy Clinics of North America|November 19, 2025
Current Concepts for Diagnosing Non-Dysplastic and Dysplastic Barrett's EsophagusMatthew Stachler, Yekta Metanat, Joseph Willis
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 16, 2014
Filter Paper-based Nucleic Acid Storage in High-throughput Solid Tumor GenotypingMatthew Stachler, Yonghui Jia, Nematullah Sharaf, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 10, 2018
Mutational landscape of goblet cell carcinoids and adenocarcinoma ex goblet cell carcinoids of the appendix is distinct from typical carcinoids and colorectal adenocarcinomasMelanie Johncilla, Matthew Stachler, Joseph Misdraji, et al.
Genes|July 27, 2022
Pilot Study Showing Feasibility of Phosphoproteomic Profiling of Pathway-Level Molecular Alterations in Barrett's EsophagusJarrod Moore, Ryan Hekman, Benjamin C Blum, et al.
The American Journal of Gastroenterology|February 25, 2026
Adjunctive Use of p53 Immunohistochemistry for Risk Stratification in Barrett's Esophagus: A Systematic Review and Meta-AnalysisTarek Sawas, Perica Davitkov, Margaret Zhou, et al.
Cold Spring Harbor Molecular Case Studies|June 2, 2021
Twists and turns from "tumor in tumor" profiling: surveillance of chronic lymphocytic leukemia (CLL) leads to detection of a lung adenocarcinoma, whose genomic characterization alters the original hematologic diagnosisPanieh Terraf, Lynette M Sholl, Matthew S Davids, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
Critical role for IL-1β in DNA damage-induced mucositisNaama Kanarek, Sergei I Grivennikov, Michael Leshets, et al.
Nature Communications|January 7, 2017
CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinomaJin Zhou, Zhong Wu, Gabrielle Wong, et al.
Gut|June 10, 2018
Subtypes of Barrett's oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysisMing Yu, Sean K Maden, Matthew Stachler, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Concerted epithelial and stromal changes during progression of Barrett's Esophagus to invasive adenocarcinoma exposed by multi-scale, multi-omics analysisMichael K Strasser, David L Gibbs, Philippe Gascard, et al.
Pageof 2